Upadacitinib

Drug Name
Upadacitinib

Brand Name(s)
Rinvoq®

Drug Class
Janus Kinase (JAK) Inhibitor

Upadacitinib is a DMARD used to treat inflammatory types of arthritis, such as rheumatoid arthritis (RA).


This information was last updated January 2020, with expert advice from:

Jason Kielly, B.Sc. (Pharm.), Pharm.D.
Associate Professor, School of Pharmacy, Memorial University of Newfoundland
Clinical Pharmacist, Rheumatic Health Program, Eastern Health

Hamidreza Izadpanah , Pharm.D.


 Go Back to Drug Index